Literature DB >> 7858416

Protein kinases in normal and transformed melanocytes.

R Y Quong1, S T Bickford, Y L Ing, B Terman, M Herlyn, N J Lassam.   

Abstract

Aberrant function of protein kinases has been implicated in the development of melanoma. In an effort to define the molecular events involved in initiation and progression of this malignancy, we used RT-PCR to identify protein kinases in both normal and transformed melanocytes. Collectively, we identified seven clones corresponding to previously characterized protein kinases (JAK-1, TYK02, AXL/UFO, IGF1-R, KDR and FER) as well as the recently identified MLK-3/PTK1 protein kinase. Northern analysis was used to determine the expression pattern of each protein kinase in both normal melanocytes and a variety of melanoma cell lines. Relatively abundant levels of UFO/AXL and KDR mRNAs were observed in a subset of the melanoma cell lines whereas most of the remaining protein kinases were expressed at similar levels in both normal and transformed melanocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7858416     DOI: 10.1097/00008390-199410000-00008

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  20 in total

1.  Selenium-containing histone deacetylase inhibitors for melanoma management.

Authors:  Raghavendra Gowda; Subbarao V Madhunapantula; Dhimant Desai; Shantu Amin; Gavin P Robertson
Journal:  Cancer Biol Ther       Date:  2012-06-06       Impact factor: 4.742

2.  Seven novel and stable translocations associated with oncogenic gene expression in malignant melanoma.

Authors:  Ichiro Okamoto; Christine Pirker; Martin Bilban; Walter Berger; Doris Losert; Christine Marosi; Oskar A Haas; Klaus Wolff; Hubert Pehamberger
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

3.  Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4.

Authors:  Natalie Nguyen; Arati Sharma; Nhung Nguyen; Arun K Sharma; Dhimant Desai; Sung Jin Huh; Shantu Amin; Craig Meyers; Gavin P Robertson
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-19

Review 4.  Biology of the TAM receptors.

Authors:  Greg Lemke
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-11-01       Impact factor: 10.005

5.  Melanoma prevention using topical PBISe.

Authors:  Chin-Ying Chung; SubbaRao V Madhunapantula; Dhimant Desai; Shantu Amin; Gavin P Robertson
Journal:  Cancer Prev Res (Phila)       Date:  2011-03-02

6.  Functional erythropoietin autocrine loop in melanoma.

Authors:  Suresh M Kumar; Geza Acs; Dong Fang; Meenhard Herlyn; David E Elder; Xiaowei Xu
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

7.  Activated tyrosine kinases in gastrointestinal stromal tumor with loss of KIT oncoprotein expression.

Authors:  Yuqing Tu; Rui Zuo; Nan Ni; Grant Eilers; Duolin Wu; Yuting Pei; Zuoming Nie; Yeqing Wu; Yuehong Wu; Wen-Bin Ou
Journal:  Cell Cycle       Date:  2018-12-04       Impact factor: 4.534

8.  Biological properties and gene expression associated with metastatic potential of human osteosarcoma.

Authors:  Tetsuhiro Nakano; Masachika Tani; Yasunori Ishibashi; Kenji Kimura; Yong-Bum Park; Natsuko Imaizumi; Hiroyuki Tsuda; Kazuhiko Aoyagi; Hiroki Sasaki; Susumu Ohwada; Jun Yokota
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 9.  TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

10.  Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma.

Authors:  Anna Gustafsson; Anna-Karin Boström; Börje Ljungberg; Håkan Axelson; Björn Dahlbäck
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.